Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis

NCT03091777 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

871

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Vaginosis

Interventions

DRUG: GDC-229
DRUG: Metronidazole Vaginal Gel 0.75%
DRUG: Placebo

Sponsor

Balmoral Medical company

Collaborators

[object Object]